Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT)

Vogel, Arndt; Römmler-Zehrer, Josefine; Li, Jack Shiansong; McGovern, Desmond; Romano, Alfredo; Stahl, Michael

doi:10.1186/s12885-016-2798-8

BMC Cancer

Article metrics
Last updated: Sat, 20 Apr 2024 4:42:07 Z

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT)

Access & Citations

3155

Article Accesses
23

Web of Science
22

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com